(Q73234982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Combined use of type A and F botulinum toxins for blepharospasm: a double-blind controlled trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

T Mezaki

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Kaji

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M F Brin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Hirota-Katayama

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Kubori

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Shimizu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

J Kimura

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 November 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

1017-1020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

Botulinum toxin in movement disorders

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Development of resistance to botulinum toxin type A in patients with torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Response and immunoresistance to botulinum toxin injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Comparison of therapeutic efficacies of type A and F botulinum toxins for blepharospasm: a double-blind, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Dose-response curve of human extensor digitorum brevis muscle function to intramuscularly injected botulinum toxin type A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in human

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Quantifying how location and dose of botulinum toxin injections affect muscle paralysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Botulinum a toxin for spasmodic torticollis: multiple vs single injection points per muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

Further studies using higher doses of botulinum toxin type F for torticollis resistant to botulinum toxin type A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28199911%2914%3A6%3C1017%3A%3AAID-MDS1018%3E3.0.CO%3B2-3

10.1002/1531-8257(199911)14:6<1017::AID-MDS1018>3.0.CO;2-3

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10584680%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference